The OxyMask™ development and performance in healthy volunteers
James E Paul1, Horia Hangan2, Julius Hajgato31Department of Anesthesia, McMaster University, Hamilton, ON, Canada; 2Faculty of Engineering, The University of Western Ontario, London, ON, Canada; 3Southmedic Inc., Barrie, ON, CanadaBackground: The OxyMask™ is a unique, open-style, oxyge...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/1402bc94901c4a27b3d5540cb662c7e6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:1402bc94901c4a27b3d5540cb662c7e6 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:1402bc94901c4a27b3d5540cb662c7e62021-12-02T02:39:25ZThe OxyMask™ development and performance in healthy volunteers1179-1470https://doaj.org/article/1402bc94901c4a27b3d5540cb662c7e62008-12-01T00:00:00Zhttp://www.dovepress.com/the-oxymasktrade-development-and-performance-in-healthy-volunteers-a2712https://doaj.org/toc/1179-1470James E Paul1, Horia Hangan2, Julius Hajgato31Department of Anesthesia, McMaster University, Hamilton, ON, Canada; 2Faculty of Engineering, The University of Western Ontario, London, ON, Canada; 3Southmedic Inc., Barrie, ON, CanadaBackground: The OxyMask™ is a unique, open-style, oxygen mask that was originally developed in 2005. The original mask was modified, using computational fluid dynamics numerical simulations, with the goal of allowing it to produce a wider range of FiO2. This analysis was used to guide the modification of the mask shell and the location for the oxygen diffuser.Methods: The new OxyMask was attached to 10 healthy subjects and used to deliver escalating levels of oxygen (1.5, 2, 2.5, 3, 5, 10, 15, 20, 25 and 30 LPM) for 90 seconds at each level and the resulting FiO2 was recorded (at the lips) from 5 consecutive measurements at each oxygen flow rate.Results: Mean FiO2 was 25.4% at 1.5 LPM of oxygen, 30.1% at 2 LPM, 36.5% at 2.5 LPM, 41.8% at 3 LPM, 57.6% at 5 LPM, 74.4% at 10 LPM, and 80.1% at 15 LPM. Each FiO2 achieved at these escalating oxygen levels was significantly greater than all the previous levels. The mean FiO2 was 82.8 at 20 LPM, 84.2% at 25 LPM and 84.3% at 30 LPM. All of these values on average were not significantly greater than the FiO2 achieved with 15 LPM. In a few subjects a maximum FiO2 of 90% was reached.Conclusion: The original OxyMask was successfully modified so that the second generation of the mask can provide a wide range of FiO2, from 25% to 90%, while keeping its unique open design.Keywords: oxygen, oxygen masks, oxygen therapy, OxyMask™, OxyArm™, clinical trial, computational fluid dynamics (CFD), equipment design, biomedical engineering James E PaulHoria HanganJulius HajgatoDove Medical PressarticleMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2009, Iss default, Pp 9-17 (2008) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medical technology R855-855.5 |
| spellingShingle |
Medical technology R855-855.5 James E Paul Horia Hangan Julius Hajgato The OxyMask™ development and performance in healthy volunteers |
| description |
James E Paul1, Horia Hangan2, Julius Hajgato31Department of Anesthesia, McMaster University, Hamilton, ON, Canada; 2Faculty of Engineering, The University of Western Ontario, London, ON, Canada; 3Southmedic Inc., Barrie, ON, CanadaBackground: The OxyMask™ is a unique, open-style, oxygen mask that was originally developed in 2005. The original mask was modified, using computational fluid dynamics numerical simulations, with the goal of allowing it to produce a wider range of FiO2. This analysis was used to guide the modification of the mask shell and the location for the oxygen diffuser.Methods: The new OxyMask was attached to 10 healthy subjects and used to deliver escalating levels of oxygen (1.5, 2, 2.5, 3, 5, 10, 15, 20, 25 and 30 LPM) for 90 seconds at each level and the resulting FiO2 was recorded (at the lips) from 5 consecutive measurements at each oxygen flow rate.Results: Mean FiO2 was 25.4% at 1.5 LPM of oxygen, 30.1% at 2 LPM, 36.5% at 2.5 LPM, 41.8% at 3 LPM, 57.6% at 5 LPM, 74.4% at 10 LPM, and 80.1% at 15 LPM. Each FiO2 achieved at these escalating oxygen levels was significantly greater than all the previous levels. The mean FiO2 was 82.8 at 20 LPM, 84.2% at 25 LPM and 84.3% at 30 LPM. All of these values on average were not significantly greater than the FiO2 achieved with 15 LPM. In a few subjects a maximum FiO2 of 90% was reached.Conclusion: The original OxyMask was successfully modified so that the second generation of the mask can provide a wide range of FiO2, from 25% to 90%, while keeping its unique open design.Keywords: oxygen, oxygen masks, oxygen therapy, OxyMask™, OxyArm™, clinical trial, computational fluid dynamics (CFD), equipment design, biomedical engineering |
| format |
article |
| author |
James E Paul Horia Hangan Julius Hajgato |
| author_facet |
James E Paul Horia Hangan Julius Hajgato |
| author_sort |
James E Paul |
| title |
The OxyMask™ development and performance in healthy volunteers |
| title_short |
The OxyMask™ development and performance in healthy volunteers |
| title_full |
The OxyMask™ development and performance in healthy volunteers |
| title_fullStr |
The OxyMask™ development and performance in healthy volunteers |
| title_full_unstemmed |
The OxyMask™ development and performance in healthy volunteers |
| title_sort |
oxymask™ development and performance in healthy volunteers |
| publisher |
Dove Medical Press |
| publishDate |
2008 |
| url |
https://doaj.org/article/1402bc94901c4a27b3d5540cb662c7e6 |
| work_keys_str_mv |
AT jamesepaul theoxymaskamptradedevelopmentandperformanceinhealthyvolunteers AT horiahangan theoxymaskamptradedevelopmentandperformanceinhealthyvolunteers AT juliushajgato theoxymaskamptradedevelopmentandperformanceinhealthyvolunteers AT jamesepaul oxymaskamptradedevelopmentandperformanceinhealthyvolunteers AT horiahangan oxymaskamptradedevelopmentandperformanceinhealthyvolunteers AT juliushajgato oxymaskamptradedevelopmentandperformanceinhealthyvolunteers |
| _version_ |
1718402270862770176 |